<?xml version="1.0" encoding="UTF-8"?>
<p>Most case-patients received corticosteroids even though their use has been shown to be no more effective than placebo or no treatment in reducing the number of deaths and the need for blood transfusion 
 <xref rid="pntd.0001614-Panpanich1" ref-type="bibr">[39]</xref>. Two recent reviews found insufficient evidence to justify the use of corticosteroids in managing dengue shock syndrome and recommended that corticosteroids not be used to treat dengue 
 <xref rid="pntd.0001614-Panpanich1" ref-type="bibr">[39]</xref>, 
 <xref rid="pntd.0001614-Rajapakse1" ref-type="bibr">[40]</xref>. In addition, there is no convincing physiological rationale for their use and there are multiple potential side effects including stress ulceration and upper gastrointestinal bleeding in critically ill patients, hyperglycemia, and immunosuppression with an increased risk for infection.
</p>
